Aspirin in the secondary prevention of cardiovascular disease

N Engl J Med. 2013 Jan 17;368(3):204-5. doi: 10.1056/NEJMp1213380.

Authors

Anand K Parekh¹, James M Galloway, Yuling Hong, Janet S Wright

Affiliation

¹ Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Washington, DC, USA.

PMID: 23323896
DOI: 10.1056/NEJMp1213380

No abstract available

MeSH terms

Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Humans
Platelet Aggregation Inhibitors / therapeutic use*
Preventive Medicine
Secondary Prevention*

Substances

Platelet Aggregation Inhibitors
Aspirin